WEST PHARMACEUTICAL SERVICES INC - COM (WST)

Historical Holders from Q1 2014 to Q1 2025

Symbol
WST on NYSE
CUSIP
955306105
Type / Class
Equity / COM
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
69.6M
Holdings value
$22.8B
% of all portfolios
0.011%
Grand Portfolio weight change
+0.001%
Number of holders
733
Number of buys
349
Number of sells
-329
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of WEST PHARMACEUTICAL SERVICES INC - COM (WST)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1.99M $446M +$15.4M $223.88 92
2024 Q4 69.6M $22.8B +$488M $327.56 733
2024 Q3 67.6M $20.2B -$216M $300.16 722
2024 Q2 68.3M $22.5B +$203M $329.39 766
2024 Q1 67.7M $26.7B -$227M $395.71 772
2023 Q4 67.7M $23.8B +$203M $352.12 764
2023 Q3 67M $25.1B +$166M $375.21 742
2023 Q2 67.2M $25.6B -$805M $382.47 715
2023 Q1 65.8M $22.7B +$354M $346.47 672
2022 Q4 69M $16.2B +$15.8M $235.35 614
2022 Q3 68.1M $16.8B -$360M $246.08 605
2022 Q2 68.1M $20.5B -$170M $302.37 630
2022 Q1 67.9M $27.8B -$2.82M $410.71 685
2021 Q4 67.7M $31.6B +$704M $469.01 711
2021 Q3 66.1M $27.9B -$686M $424.54 659
2021 Q2 68.4M $24.4B +$165M $359.10 624
2021 Q1 67.7M $19B +$70.2M $281.78 577
2020 Q4 68.6M $19.4B +$199M $283.31 574
2020 Q3 66.1M $18.1B -$198M $274.90 558
2020 Q2 67.9M $15.5B +$456M $227.17 508
2020 Q1 66.6M $10.1B -$43.4M $152.25 451
2019 Q4 67.5M $10.1B +$89.9M $150.33 434
2019 Q3 67.1M $9.51B -$51M $141.82 395
2019 Q2 67.2M $8.41B +$89.4M $125.15 361
2019 Q1 67.8M $7.47B -$154M $110.20 368
2018 Q4 69.3M $6.79B +$37M $98.03 341
2018 Q3 68.7M $8.48B +$105M $123.47 345
2018 Q2 69M $6.85B -$60.5M $99.29 312
2018 Q1 70.2M $6.2B +$35.3M $88.29 321
2017 Q4 69.7M $6.87B -$50.7M $98.67 330
2017 Q3 69.8M $6.72B +$236M $96.26 297
2017 Q2 67.2M $6.36B +$125M $94.52 308
2017 Q1 65.7M $5.37B +$388M $81.61 285
2016 Q4 66.2M $5.62B +$86M $84.83 280
2016 Q3 66.2M $4.93B +$54.1M $74.50 270
2016 Q2 65.3M $4.96B -$130M $75.88 281
2016 Q1 65.2M $4.52B +$73.9M $69.32 239
2015 Q4 65.6M $3.95B -$8.12M $60.22 242
2015 Q3 67.5M $3.65B +$3.55M $54.12 245
2015 Q2 66.6M $3.87B +$17.9M $58.08 216
2015 Q1 67.2M $4.04B +$108M $60.21 211
2014 Q4 65.6M $3.49B -$15.4M $53.24 221
2014 Q3 66.2M $2.96B +$86.2M $44.76 212
2014 Q2 64.5M $2.72B +$34.7M $42.18 220
2014 Q1 63.6M $2.8B +$37.3M $44.05 222